SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-16-000064
Filing Date
2016-05-06
Accepted
2016-05-06 13:42:42
Documents
47
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q033116.htm 10-Q 868162
2 ex12.htm EX-12 62345
3 exhibit31_1.htm EX-31 12931
4 exhibit31_2.htm EX-31 12913
5 exhibit32_1.htm EX-32 3362
6 exhibit32_2.htm EX-32 3296
  Complete submission text file 0001367644-16-000064.txt   3607951

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ebs-20160331.xml EX-101.INS 581363
8 XBRL TAXONOMY EXTENSION SCHEMA ebs-20160331.xsd EX-101.SCH 26839
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20160331_cal.xml EX-101.CAL 60162
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20160331_def.xml EX-101.DEF 111631
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20160331_lab.xml EX-101.LAB 425316
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20160331_pre.xml EX-101.PRE 242840
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 161627140
SIC: 2834 Pharmaceutical Preparations